Matches in DBpedia 2016-04 for { <http://wikidata.dbpedia.org/resource/Q2212643> ?p ?o }
Showing triples 1 to 16 of
16
with 100 triples per page.
- Q2212643 abstract "Ocriplasmin (trade name Jetrea) is a recombinant protease with activity against fibronectin and laminin, components of the vitreoretinal interface. It is used for treatment of symptomatic vitreomacular adhesion, for which it received FDA approval on 17 October 2012. It works by dissolving the proteins that link the vitreous to the macula, resulting in posterior detachment of the vitreous from the retina.".
- Q2212643 wikiPageWikiLink Q14819473.
- Q2212643 wikiPageWikiLink Q169342.
- Q2212643 wikiPageWikiLink Q180609.
- Q2212643 wikiPageWikiLink Q212410.
- Q2212643 wikiPageWikiLink Q326710.
- Q2212643 wikiPageWikiLink Q58345.
- Q2212643 wikiPageWikiLink Q747023.
- Q2212643 wikiPageWikiLink Q7937230.
- Q2212643 type ChemicalSubstance.
- Q2212643 type Drug.
- Q2212643 type ChemicalObject.
- Q2212643 type Thing.
- Q2212643 type Q8386.
- Q2212643 comment "Ocriplasmin (trade name Jetrea) is a recombinant protease with activity against fibronectin and laminin, components of the vitreoretinal interface. It is used for treatment of symptomatic vitreomacular adhesion, for which it received FDA approval on 17 October 2012. It works by dissolving the proteins that link the vitreous to the macula, resulting in posterior detachment of the vitreous from the retina.".
- Q2212643 label "Ocriplasmin".